Oscar Health, Inc. (OSCR) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Healthcare Plans
EV/EBITDA
N/A
—
5yr avg: 35.77
30Y Low35.8·High35.8
P/FCF
↑
4.45
↑+51% vs avg
5yr avg: 2.94
30Y Low1.5·High3.8
P/B Ratio
↑
4.80
↑+109% vs avg
5yr avg: 2.29
30Y Low0.6·High3.8
ROE
↑
-44.4%
↓+83% vs avg
5yr avg: -262.3%
30Y Low-53%·High3%
Debt/EBITDA
N/A
—
5yr avg: 4.57
30Y Low4.6·High4.6
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
OSCR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Oscar Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 4.4x P/FCF, 51% above the 5-year average of 2.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.7B | $3.8B | $3.6B | $2.0B | $523M | $1.4B | — | — |
| Enterprise Value | $2.4B | $1.4B | $2.3B | $457M | $-737908447 | $301M | — | — |
| P/E Ratio → | -10.62 | — | 140.44 | — | — | — | — | — |
| P/S Ratio | 0.40 | 0.32 | 0.39 | 0.35 | 0.13 | 0.73 | — | — |
| P/B Ratio | 4.80 | 3.84 | 3.52 | 2.52 | 0.59 | 1.01 | — | — |
| P/FCF | 4.45 | 3.56 | 3.76 | — | 1.49 | — | — | — |
| P/OCF | 4.30 | 3.44 | 3.65 | — | 1.37 | — | — | — |
P/E links to full P/E history page with 30-year chart
OSCR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.12 | 0.26 | 0.08 | -0.18 | 0.16 | — | — |
| EV / EBITDA | — | — | 35.77 | — | — | — | — | — |
| EV / EBIT | — | — | 41.03 | — | — | — | — | — |
| EV / FCF | — | 1.35 | 2.47 | — | -2.10 | — | — | — |
OSCR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Oscar Health, Inc. earns an operating margin of -3.4%. Operating margins have expanded from -4.6% to -3.4% over the past 3 years, signaling improving operational efficiency. A negative ROE of -44.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.4% | 14.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -3.4% | -3.4% | 0.4% | -4.6% | -14.8% | -29.7% | -68.8% | -46.8% |
| Net Profit Margin | -3.8% | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | -69.0% | -47.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -44.4% | -44.4% | 2.8% | -31.9% | -53.1% | -1185.2% | — | — |
| ROA | -7.9% | -7.9% | 0.6% | -6.7% | -15.4% | -20.5% | -22.5% | -19.4% |
| ROIC | — | — | — | — | — | -148.3% | — | — |
| ROCE | -25.3% | -25.3% | 1.2% | -10.6% | -41.1% | -48.4% | -22.4% | — |
OSCR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $2.8B exceeds total debt of $430M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.44 | 0.29 | 0.37 | 0.33 | — | — | — |
| Debt / EBITDA | — | — | 4.57 | — | — | — | — | — |
| Net Debt / Equity | — | -2.39 | -1.21 | -1.95 | -1.41 | -0.79 | — | — |
| Net Debt / EBITDA | — | — | -18.72 | — | — | — | — | — |
| Debt / FCF | — | -2.21 | -1.29 | — | -3.59 | — | -3.28 | — |
| Interest Coverage | -22.52 | -22.52 | 1.41 | -10.86 | -26.97 | -120.89 | -115.48 | — |
Net cash position: cash ($2.8B) exceeds total debt ($430M)
OSCR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.95x is below 1.0, meaning current liabilities exceed current assets — though the company's $2.8B cash position helps mitigate short-term liquidity concerns. The current ratio has improved from 0.90x to 0.95x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.95 | 0.95 | 0.90 | — | 1.26 | 1.71 | — | — |
| Quick Ratio | 0.95 | 0.95 | 0.90 | — | 1.26 | 1.71 | — | — |
| Cash Ratio | 0.82 | 0.82 | 0.68 | — | 0.91 | 1.05 | — | — |
| Asset Turnover | — | 1.85 | 1.90 | 1.63 | 0.91 | 0.58 | 0.26 | 0.41 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
OSCR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Oscar Health, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.7% | — | — | — | — | — |
| FCF Yield | 22.5% | 28.1% | 26.6% | — | 67.2% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $262M | $266M | $222M | $212M | $179M | $239M | $239M |
Peer Comparison
Compare OSCR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 OSCRYou | $5B | -10.6 | — | 4.4 | 14.4% | -3.4% | -44.4% | — | — |
 CLOV | $1B | -15.4 | — | — | 103.6% | -4.4% | -26.3% | -34.0% | — |
 ALHC | $4B | -4945.9 | 77.3 | 33.0 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 ACGL | $34B | 8.1 | 6.8 | 5.5 | 37.2% | 25.0% | 19.5% | 15.4% | 0.5 |
 BHVN | $1B | -1.4 | — | — | — | — | -310.8% | -242.1% | — |
 MIRA | $40M | -2.0 | — | — | — | — | -238.9% | — | — |
 UNH | $330B | 27.5 | 16.5 | 20.5 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $103B | 58.1 | 12.5 | 13.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 CI | $73B | 12.4 | 8.2 | 8.7 | 9.5% | 3.3% | 14.3% | 10.4% | 2.7 |
 ELV | $80B | 14.7 | 10.8 | 25.3 | 25.6% | 4.1% | 13.3% | 9.1% | 3.4 |
 CNC | $26B | -3.9 | — | 6.1 | 12.2% | -3.9% | -28.7% | -21.6% | — |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See OSCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OSCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OSCR vs CLOV
Side-by-side business, growth, and profitability comparison vs Clover Health Investments, Corp..
Start ComparisonOSCR — Frequently Asked Questions
Quick answers to the most common questions about buying OSCR stock.
What is Oscar Health, Inc.'s P/E ratio?
Oscar Health, Inc.'s current P/E ratio is -10.6x. The historical average is 140.4x.
What is Oscar Health, Inc.'s ROE?
Oscar Health, Inc.'s return on equity (ROE) is -44.4%. The historical average is -31.6%.
Is OSCR stock overvalued?
Based on historical data, Oscar Health, Inc. is trading at a P/E of -10.6x. Compare with industry peers and growth rates for a complete picture.
What are Oscar Health, Inc.'s profit margins?
Oscar Health, Inc. has 14.4% gross margin and -3.4% operating margin.